Biohazard, Genetics and Regulation - Clinical Research Informer

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Biohazard

Genetics

Regulation

Thinking About the Box: Considerations for Transport of Investigational Products

Advarra

OCTOBER 26, 2023

Controlled Environment and IP Containment The potential for a release, and the risk associated with a genetically engineered IP, are part of the IBC’s assessment purview under National Institutes of Health (NIH) Guidelines. And don’t forget to affix a biohazard sticker to the exterior for quick and clear identification.

Production

Production Containment Biohazard Biohazard

IBC vs. IRB: What’s the Difference?

Advarra

JUNE 12, 2023

Gene therapy research is exciting and full of promise, but because of the risks involved, it’s also highly regulated, requiring an institutional biosafety committee (IBC) to provide additional oversight and risk assessment. What do the Regulations Say about IBC Review? What Does an IBC Review? How is IBC Membership Composed?

Genetic Engineering

Genetic Engineering Gene Therapy Genetics Engineer

Thinking About the Box: Considerations for Transport of Investigational Products

IBC vs. IRB: What’s the Difference?

Stay Connected